MNKD Stock Summary and Trading Ideas (Mannkind | NASDAQ:MNKD)

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

What symbol and exchange does Mannkind shares trade?

Mannkind trades on the NASDAQ stock market under the symbol MNKD.

What is Mannkind stock price doing today?

As of July 24, 2026, MNKD stock price climbed to $4.13 with 8,004,292 million shares trading.

What is Mannkind's Beta?

MNKD has a beta of 2.79, meaning it tends to be more sensitive to market movements. MNKD has a correlation of 0.17 to the broad based SPY ETF.

How much is Mannkind worth?

MNKD has a market cap of $1.25 billion. This is considered a Small Cap stock.

How much money does Mannkind make?

Last quarter Mannkind reported $90 million in Revenue and -$.02 earnings per share. This fell short of revenue expectation by $-15 million and missed earnings estimates by -$.03.

What is the highest and lowest price Mannkind traded in the last 3 year period?

In the last 3 years, MNKD traded as high as $7.63 and as low as $2.23.

What are the top ETFs holding Mannkind?

The top ETF exchange traded funds that MNKD belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.

Is Mannkind (MNKD) a good investment?

MNKD has underperformed the market in the last year with a return of +1.2%, while SPY returned +17.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in MNKD shares. However, MNKD has outperformed the market in the last 3 month and 2 week periods, returning +53.0% and +1.0%, while SPY returned +3.8% and -2.1%, respectively. This indicates MNKD has been having a stronger performance recently.

What are the support and resistance levels for Mannkind (MNKD)?

MNKD support price is $3.73 and resistance is $4.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MNKD shares will trade within this expected range on the day.